New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2014
08:07 EDTLJPCLa Jolla Pharmaceutical receives notice of allowance for patent
La Jolla Pharmaceutical Company announced that the United States Patent and Trademark Office has issued a notice of allowance for patent application number 13/888,158 covering methods of treating chronic inflammation using modified pectin. Specifically, the patent, which expires in 2025 without taking into account patent term extension, provides proprietary protection for methods of treating chronic inflammation by administration of modified pectin with a molecular weight greater than 25 kilodaltons.
News For LJPC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
10:58 EDTLJPCDeutsche Bank biotech analyst holds an analyst/industry conference call
Subscribe for More Information
May 15, 2015
09:56 EDTLJPCTang Capital increases stake in La Jolla Pharmaceutical to 15.3%
Subscribe for More Information
May 8, 2015
09:28 EDTLJPCOn The Fly: Pre-market Movers
Subscribe for More Information
06:23 EDTLJPCLa Jolla to host business news update conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use